Dr. Sindelar is a Professor and Former Dean, Faculty of Pharmaceutical Sciences. Dr. Sindelar is also an elected fellow of the Canadian Academy of Health Sciences, and elected fellow of the International Pharmaceutical Federation (FIP), Chair of the Global Pharmacy Observatory Advisory Board of FIP, and Member of the External Advisory Board, Trinity College Dublin, School of Pharmacy and Pharmaceutical Sciences. In addition, he previously was appointed Vice President of Innovation, Research & Academic Affairs at Providence Health Care, President of the Providence Health Care Research Institute and Associate Dean Research in the UBC Faculty of Medicine (2013-2016). In these various roles, Dr. Sindelar has and continues to contribute to research, health policy, team-building, international partnerships, as well as strategic innovations. His research expertise is in medicinal chemistry, computer-aided drug discovery, and pharmaceutical biotechnology. Dr. Sindelar is the recipient of several School and University-wide teaching honors during his academic career. He has co-edited 5 editions of the highly successful textbook entitled “Pharmaceutical Biotechnology: Fundamentals and Applications.” While serving as Dean at UBC, he was instrumental in the fundraising, design and building of a new 250,000 sqft building that has won numerous awards for design, functionality and innovation. He has taught in the professional and graduate curriculum and serves on scientific advisory and editorial boards. In addition, he is a founder of the Centre for Drug Research and Development (formerly CDRD, now called adMare BioInnovations), a national not-for-profit drug development and commercialization centre that provides expertise and infrastructure to enable researchers to advance promising early-stage drug candidates.

Prof. Molokhia obtained his PhD from the University of Michigan, USA 1973. He held academic positions at Universities of Houston, Riyadh and Alexandria and is a current member of the Egyptian National Pharmacology Committee. He advised more than 52 PhD and MS candidates and co-authored more than 158 original manuscripts and presentations to national and international conferences. Between 1996-2004, he was the chairman of the Egyptian National Organization for Drug Control and Research at the Ministry of Health. From 2004 until 2013, he chaired the European Egyptian Pharmaceutical Industries Company, a division of Pharco Pharmaceuticals, Alexandria, Egypt. Between 2007-2013, he chaired the Pharmaceutical Sector of the Pharmaceuticals and Cosmetic Chamber at the Egyptian Industry Union. Prof. Molokhia chaired several conferences organized among NODCAR, the MOH and the WHO. As consultant to the WHO, he presented training and consultations to nine countries in the EMRO region. Prof. Molokhia co-chaired 5 Egyptian-USP Symposia on “Science and Standards”. He acts as observer representing the Egyptian Chamber of Pharmaceuticals with the USP Convention.

John Papastergiou graduated from the Leslie Dan Faculty of Pharmacy, University of Toronto in 2002. After graduation he was employed as a staff pharmacist at Sunnybrook Health Sciences Center. In 2005, John joined Shoppers Drug Mart and acquired his first store at Pape and Danforth. He now owns and operates four locations in downtown Toronto. In 2014, John received an appointment as an adjunct assistant professor at the School of Pharmacy, University of Waterloo. In 2016, he was cross appointed at the Leslie Dan Faculty of Pharmacy, University of Toronto. In addition to managing a large business, John employs his unique background in clinical research to explore an expanded role for the community pharmacist. John strongly believes that the accessibility of the community pharmacist places them in a unique position to actively screen and monitor patients for various chronic diseases. Most recently, he implemented one of the first frontline community pharmacist-directed pharmacogenomics clinics in Canada. His work in this area won first prize at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Buenos Aires, Argentina. John can be heard regularly on the Libby Fights Back Show on AM740 Zoomer Radio and on his top-rated podcast The Pharmacists Are In. In 2012, John was named the Shoppers Drug Mart Associate of the Year. In 2014, he received the OPA Mentorship Award and was named CPhA Canadian Pharmacist of the Year. In 2016, he was the recipient of the OPA Voice of the Profession Award and was awarded the Pharmacy Practice Commitment to Care Award for Overall Patient Care. In 2019, John was named by the International Forum on Advancement in Healthcare as one of the top 100 healthcare leaders globally. He was also presented with the OPA Award for Excellence in Research and Academia.

He is a Professor of Governance Practices, the President of Value Institution for postgraduate education, a Visiting Professor and Thesis advisor at various academic institutions and a faculty member of governance workgroup at Cambridge Worldwide Academy; U.K., Also, he worked for nine years as part-time consultant at WHO-EMRO. Dr Emad is also a founding member, vice president and secretary general of Egyptian Healthcare Society (E.H.S.). Wherein, he has extensively contributed to both scientific and entrepreneurial fields of health care and pharmacy practices governance, academic research and education, health-economics, and pharmaceutical diligence circles of pharmacoepidemiology, pharmacovigilance and medicines regulations. Dr Emad had BSc of Pharmaceutical Sciences; Master of Business Administration; A.U.C., Doctor of Pharmacy; Saskatchewan, Diploma in International-Economics; Cambridge, and PhD in Industrial Management; Aston University. Further, over the last fifteen years, he has been focusing on academic, educational and clinical governance practices domains. As a governance adviser, Dr Emad has frequently conducted in-house governance counsels and endorsements for both public and corporate organisations; directed several real-world governance oversight operations and institutional integration processes whereby, he has enacted governance initiatives in diverse contexts of postgraduate education, health and pharmacy, health care delivery, health system restructuring and social responsibility activities; and adopted an assortment of practical tools, programs, toolkits and checklists for bylaws development and legislative compliance, governance assessment and enforcement as well as stakeholders and public administration. And, as an international speaker and panellist Dr Emad frequently delivered speeches on healthcare and pharmacy governance related conferences and workshops. He authored and published in different international journals a number of books, articles, reports and curricula addressing governance theory, multi-aspect foundations of research, vocational education and health care system.

Dr. Yoshimichi Sai is Professor and Director of Department of Hospital Pharmacy, Kanazawa University. He received his B.S. (1989) in Pharmaceutics and his M.S. (1991) and Ph.D. (1994) in Biochemistry from the Kanazawa University. He is a faculty member of Graduate School of Medical Sciences, Kanazawa University. He has studied abroad for two years with Dr. Irwin M. Arias as a postdoctoral fellow at the Tufts University School of Medicine (1997-1999). Prof. Sai is the (co)-author of 169 research articles, 18 reviews, 19 book chapter, 50 invited lectures and more than 540 abstracts presented domestic and international conferences. He was awarded the Young Investigator Award, Japanese Society for the Study of Xenobiotics in 2004 and the Young Investigator Award 2002 of the Pharmaceutical Society of Japan, Hokuriku branch. His current research interests include: i) molecular biopharmaceutical study on metabolic enzymes and drug transporters as a molecular determinant of inter and intra-individual variability of drug efficacy, toxicity and disposition, ii) clinical pharmacokinetic study on monitoring and avoidance of adverse effect of drugs, iii) development of administration planning for proper use of drug, individualized medicine to improve QOL of patients. He is the current Board Director of the Japan Pharmaceutical Association, the Japanese Society of Hospital Pharmacists, and the Japanese Society of Pharmaceutical Health Care and Sciences.

Dr. Ibrahim Al-Khars is the Co-Founder & Chief Executive Officer of Afaq Alwataniyah Company and the Managing Director/Senior Consultant for People & Business Development Center, Saudi Arabia. Dr. Al-Khars has a Master in Applied Business Research from Swiss Business School, Switzerland; a Master in Business Administration specialized in International Business from the University of Florida, USA and a special diploma degree in new venture creation from the same university. He received a Bachelor degree in Pharmaceutical Science from King Saud University, Riyadh, Saudi Arabia with honor and Master Degree in Clinical Pharmacy from the same university. His academic history includes a Specialty Residency in Pharmacy Practice Management at Detroit Receiving Hospital and Wayne State University, Detroit, Michigan, USA. His research interests include health care quality improvement, health care reform, the economic evaluation of treatment strategies, health care educational system and technologies, and pharmacy practice management. In addition to his teaching and management activities, Dr. Al-Khars has conducted many presentations, executive seminars and management development programs in different countries including Saudi Arabia, USA, Germany, Malaysia, Lebanon, Oman, Egypt, and United Arab Emirates.

Stuart T. Haines, Pharm.D., BCPS, BCACP, BC-ADM is Professor (with tenure), Department of Pharmacy Practice and Director, Division of Pharmacy Professional Development at the University of Mississippi School of Pharmacy and previously Professor and Vice Chair, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy. Dr. Haines is Immediate-Past Chair of the Council of Faculties in the American Association of Colleges of Pharmacy (AACP), a Past-President of the American College of Clinical Pharmacy (ACCP), Chaired the AACP 2015-2016 Academic Affairs Committee that developed the Core Entrustable Professional Activity (EPA) statements for new pharmacy graduates, and was a member of the Task Force that petitioned the Board of Pharmacy Specialties (BPS) to recognize ambulatory care pharmacy practice as a specialty. Dr. Haines is the Editor-in-Chief of iForumRx.org, an online journal club for ambulatory care pharmacy specialists, an Associate Editor for the Journal of the American College of Clinical Pharmacy, and an Editor for the textbook Pharmacotherapy: A Pathophysiologic Approach. He has served as a Scientific Editor for the journal Pharmacotherapy and on numerous editorial boards including American Journal of Pharmaceutical Education (AJPE), Annals of Pharmacotherapy, Current Medical Research and Opinion (CMRO), the Journal of the American Pharmacists Association (JAPhA), American Journal of Health-System Pharmacy (AJHP), and the Pharmacists’/Prescribers’ Letter. He has authored more than 120 scholarly papers and book chapters regarding diabetes, cardiovascular disease, ambulatory care pharmacy practice models, and instructional methods. Dr. Haines earned his Bachelor of Science in Pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Doctor of Pharmacy from the University of Texas at Austin. He completed a Pharmacy Practice Residency at the Brigham and Women’s Hospital in Boston as well as an Ambulatory Care Pharmacy Practice Residency at the University of Texas Health Science Center in San Antonio. He is board certified in Ambulatory Care Pharmacy Practice (BCACP), Pharmacotherapy (BCPS), and Advanced Diabetes Management (BC-ADM). Dr. Haines is a fellow in the American College of Clinical Pharmacy (FCCP), American Society of Health-System Pharmacists (FASHP), and the American Pharmacists Association (FAPhA). Dr. Haines is a Distinguished Practitioner and Fellow in the National Academies of Practice (FNAP) and received the Ambulatory Care Achievement Award from the ACCP Ambulatory Care Practice and Research Network (2009) as well as the Distinguished Achievement Award in Ambulatory and Community Practice from APhA (2010). Lastly, he was the recipient of the ACCP Educator (2010) and Robert M. Elenbaas Service (2016) Awards.

Dr. Joaquima (Jackie) Serradell is senior vice president and Chief Operating Officer (COO) of the Peer Review Institute. She earned a Doctor of Pharmacy (Pharm.D.) degree at the University of Barcelona, Spain, a Masters in Public Health (MPH) and a PhD. at the University of Minnesota, Minneapolis. She undertook a post-doctoral fellowship at the United States Pharmacoepia. She has held various academic appointments at the Philadelphia College of Pharmacy, and at the University of Pennsylvania School of Medicine, before moving to the private sector, where she has been, since 2002, the vice president of Pharmasultants Group, a firm specializing in consulting for the pharmaceutical and biotechnology industries in the areas of pharmacoeconomics, epidemiology, outcomes research and policy analysis. She has performed work for US and international companies. She is a popular speaker, having spoken in Mexico, Spain, Venezuela, Dubai in addition to the United States. She is the author of a book on SARS which has just had its second edition published. She is fluent in a number of languages.

Dr. Tom Johnson received his Doctor of Pharmacy degree from North Dakota State University and completed his Pharmacy Residency at St. Alexius Medical Center and NDSU in Bismarck, North Dakota. He earned his Master of Business Administration degree from the University of Sioux Falls in 2009. From1998 through 2010, he held a shared faculty appointment with South Dakota State University and Avera McKennan Hospital in the specialty of Critical Care. He is currently the Assistant Vice President of Hospital Pharmacy at Avera Health based in Sioux Falls, South Dakota. Dr. Johnson is Board Certified in both Critical Care and Pharmacotherapy. He is also a member of many interdisciplinary and pharmacy professional organizations including the Society of Critical Care Medicine (SCCM), the American College of Clinical Pharmacy (ACCP), the American College of Healthcare Executives (ACHE), and the American Society of Health-System Pharmacists (ASHP). He has served ASHP as a Board Member (2011-2014), and then the Treasurer (2016-2019), and currently serves as President-Elect. He is a past-president of the South Dakota Society of Health-System Pharmacists and was awarded the SDSHP Pharmacist of the Year Award in 2005. In 2009, he received recognition as a Fellow of the American Society of Health-System Pharmacists and in 2012 as a Fellow of the American College of Critical Care Medicine.

Kylee is the Lead Pharmacist for Education and Services at the Society of Hospital Pharmacists (SHPA), a position she has held for seven years. Within her role, she is responsible for the development and provision of educational offerings for pharmacists and pharmacy technicians across Australia. Previous to her current position, Kylee worked as a clinical educator and oncology pharmacist in hospitals in New Zealand, the United Kingdom and Australia. Her interests include the development of pharmacists through the use of effective feedback and the integration of novel technologies into pharmacist education.

Joseph A. Zorek, PharmD, BCGP, joined The University of Texas Health Science Center at San Antonio in 2019 as Director of their Quality Enhancement Plan, "Linking Interprofessional Networks for Collaboration," and Associate Professor with Tenure in the School of Nursing. He is a board certified geriatric pharmacist whose practice interests include incorporation of pharmacists into interprofessional teams and mitigation of medication-related risks in older adults through interprofessional practice. Joe previously served as Director of Interprofessional Education (IPE) and Associate Professor at the University of Wisconsin-Madison School of Pharmacy, where he taught courses on pharmacy practice and geriatric pharmacy. His analyses of IPE accreditation standards, first published in the Journal of Interprofessional Care and later updated for invited presentations, including at the National Academy of Medicine, highlighted opportunities to utilize accreditation processes to advance IPE throughout the health professions. Joe was awarded a grant to represent the National Center for Interprofessional Practice and Education on a collaborative project with the Health Professions Accreditors Collaborative. The product of this work, "Guidance on Developing Quality Interprofessional Education for the Health Professions," was endorsed by 24 accrediting bodies in the US and released to the public in February 2019.

Dr. Bleidt is a Professor of Sociobehavioral and Administrative Pharmacy at Nova Southeastern University. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has forty years of professional experience in preventing drug use problems and substance misuse. Dr. Bleidt served fourteen years as Chair of the Program Committee for the Alcohol, Tobacco, and Other Drugs Section of the American Public Health Association and five years for the Pharmacy Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the Unites States Pharmacopoeia Convention since 1985. Dr. Bleidt has delivered over 400 presentations and published nearly fifty works. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001);and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida.

-

Janet P. Engle is the Executive Director of the Accreditation Council for Pharmacy Education (ACPE). She is past president of the American Pharmacists Association (APhA), the national professional society of pharmacists with over 60,000 members. She has served as a voting member of the FDA Nonprescription Drug Advisory Committee and continues as a Special Government Employee Consultant to FDA. Dr. Engle is a past member of the Board of Directors of the Board of Pharmacy Specialties. Dr. Engle was elected as a Distinguished Practitioner in the National Academies of Practice in Pharmacy. Dr. Engle has also been named a Fellow of the APhA Academy of Pharmacy Practice and Management and a Fellow of the American College of Clinical Pharmacy. She also has received the APhA Distinguished Achievement Award for Clinical/Pharmacotherapeutic Practice. Dr. Engle is an internationally recognized expert on the topics of nonprescription medicines, pharmacy education, and leadership and is very active in international pharmacy. She has served as Chair of the ACPE International Commission and is serving a third term as overseas expert of the Post Graduate Allied Health Institute Board at Singapore General Hospital. Dr. Engle has worked with National Taiwan University and was a guest professor at Harbin Medical University in China. She worked with the Pharmacy Council of Thailand and received an honorary PhD in Pharmaceutical Sciences from Khon Kaen University in Thailand. She has served as a consultant to the Western Pacific Region of the World Health Organization. She has practiced pharmacy in community, hospital, long-term care and pharmacy-directed ambulatory clinic settings.

-

-